Waystar Holding Business Summary

Waystar Holding Corp. (WAY) operates a premier cloud-based software platform designed to simplify healthcare payments through a dual-revenue model consisting of high-margin subscription fees (approximately 55-70% of total revenue) and transaction-based volume fees. The company’s enterprise-grade ecosystem is segmented into Provider Solutions, which automate the end-to-end revenue cycle from claim submission to denial management, and Patient Payment Solutions, which streamline consumer billing and collections. Following the strategic 2025 integration of Iodine Software, Waystar has expanded into clinical intelligence, leveraging its proprietary AltitudeAI and newly launched Agentic AI to process over 5 billion annual transactions and manage $2.4 trillion in gross claims. In a competitive landscape dominated by R1 RCM, Inovalon, Availity, and TriZetto, Waystar distinguishes itself as a pure-play technology leader, maintaining a 112% net revenue retention rate and serving over 30,000 clients, including 16 of the top 20 U.S. News Best Hospitals. Leadership is spearheaded by Chief Executive Officer Matthew J. Hawkins, who previously served as CEO of Navicure and has led Waystar since its 2017 formation via the merger of Navicure and ZirMed (founded by Jim Denny). The executive suite includes Chief Technology Officer Christopher Schremser, Chief Financial Officer Steven Oreskovich, and Chief AI + Product Officer William Chan, who oversees the firm’s advanced automation roadmap. Waystar is backed by a sophisticated roster of institutional investors and board members, including EQT (represented by Eric Liu and Ethan Waxman), Bain Capital (Paul Moskowitz), CPPIB (Sam Blaichman), and Advent International (Lauren Young). The board is chaired by John Driscoll, former President of U.S. Healthcare at Walgreens, ensuring deep industry expertise as the company targets a projected fiscal 2026 revenue midpoint of $1.284 billion.